Director Robert Langer sold $132K of Rubius Therapeutics, Inc.

Sold$131,799

$17.57Price

7,500Shares

−100%Stake

What RUBY did after the filing

Prices for RUBY after this filing aren't in yet.

Traded Mon, Apr 15. Filed Wed, Apr 17, 4:42 PM ET, after the close. Not investment advice.